Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review

• Autoři: VACULOVÁ Jitka; DOLINA Jiří; JABANDŽIEV Petr; ŠTĚRBA Martin; TŮMA Jiří; DOUŠEK Robert; PLÁNKA Ladislav; ŠENKYŘÍK Jan; ŠTĚRBA Jaroslav; BAJČIOVÁ Viera; EID Michal; PAVLOVSKÝ Zdeněk; KALA Zdeněk; KUNOVSKÝ Lumír
• Rok publikování: 2021
• Druh: Článek v odborném periodiku
• Časopis / Zdroj: Klinická onkologie
• Fakulta / Pracoviště MU: Lékařská fakulta
• www: https://www.linkos.cz/english-summary/klinicka-onkologie-journal/2021-08-15-4-en/myofibroblasticky-nador-jicnu-kazuistika-dlouhodoby-follow-up-a-prehled-literatu-1/
• Doi: http://dx.doi.org/10.48095/ccko2021313
• Klíčová slova: inflamamtory pseudotumor; esophageal carcinoma; myofibroblastic tumor; plasma cell granuloma; endoscopy; surgery
• Popis: Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm with intermediate malignant potential. Although most often seen in the lungs, it can occur at multiple anatomical locations, including the gastrointestinal tract. An esophageal lesion is extremely rare, however. IMTs present most commonly in children and young adults. The main therapeutic approach is surgical resection. Case report: We report on the follow-up of a case in a 13-year-old boy with IMT in the esophagus. He underwent surgical resection in 2013 and is free of disease to date. Conclusion: Surgical resection is the most preferred therapy. If the resection is complete, the risk of recurrence is low. Nevertheless, every patient should be carefully followed up after the resection.

Související projekty

• Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu